ASPRAEIPYBEUEV-UHFFFAOYSA-N
C45H48F10N4O6 — CID 157217755
Data last refreshed: (MolForge compound catalog, from PubChem)
About ASPRAEIPYBEUEV-UHFFFAOYSA-N
ASPRAEIPYBEUEV-UHFFFAOYSA-N (PubChem CID 157217755) has the molecular formula C45H48F10N4O6 and a molecular weight of 930.88 g/mol. Its IUPAC name is 1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-4-[4-(trifluoromethoxy)phenyl]butan-1-one;1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-3-[4-(trifluoromethoxy)phenyl]propan-1-one.
Molecular Properties
| Compound Name | ASPRAEIPYBEUEV-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 157217755 |
| Molecular Formula | C45H48F10N4O6 |
| Molecular Weight | 930.88 g/mol |
| Exact Mass | 930.34 |
| IUPAC Name | 1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-4-[4-(trifluoromethoxy)phenyl]butan-1-one;1-[4-[2-(2,4-difluorophenoxy)ethyl]piperazin-1-yl]-3-[4-(trifluoromethoxy)phenyl]propan-1-one |
| SMILES | O=C(CCCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1.O=C(CCc1ccc(OC(F)(F)F)cc1)N1CCN(CCOc2ccc(F)cc2F)CC1 |
| InChI | InChI=1S/C23H25F5N2O3.C22H23F5N2O3/c24-18-6-9-21(20(25)16-18)32-15-14-29-10-12-30(13-11-29)22(31)3-1-2-17-4-7-19(8-5-17)33-23(26,27)28;23-17-4-7-20(19(24)15-17)31-14-13-28-9-11-29(12-10-28)21(30)8-3-16-1-5-18(6-2-16)32-22(25,26)27/h4-9,16H,1-3,10-15H2;1-2,4-7,15H,3,8-14H2 |
| InChIKey | ASPRAEIPYBEUEV-UHFFFAOYSA-N |
| XLogP | 8.43 |
| TPSA | 84.02 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 65 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 930.88 |
| LogP ≤ 5 | 8.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157217755 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.